glp 1 average weight loss per month Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained GLP-1 Agonists In Obesity

Start every meal with protein

The drug is known as a triple-agonist, meaning it targets three different receptors in the brain and throughout the body

M.BuseJ

Drug Class Analysis GLP-1 Weight Loss Drug Market by Drug Class: Injectable and Dual Agonist Therapies Command 78.4% of Revenue Drug Class Revenue Share, CAGR, and Commercial Drivers GLP-1 Obesity Drug Market 2026 Injectable GLP-1 receptor agonist monoagonists hold a 32.8% GLP-1 market revenue share in 2026 , reflecting Wegovys position as the most commercially successful weight management drug in pharmaceutical history

Moreover, emerging research suggests that targeting both the GLP-1 and GIP pathways may lead to synergistic effects on body weight, glucose control, and cardiovascular health

A central question is whether these hormones can treat or prevent cancer by modulating the immune TME and tumor cell metabolism